Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve.

Fishman, Jay A; Grossi, Paolo A

Fishman, Jay A; Grossi, Paolo A.

Fishman JA; Transplant Infectious Disease Program, Infectious Disease Division, and MGH Transplantation Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Grossi PA; Infectious Diseases Department, University of Insubria, Varese, Italy.

Am J Transplant ; 20(7): 1765-1767, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-20869

Subject(s)

Coronavirus Infections/complications; Coronavirus Infections/prevention & control; Immunocompromised Host; Pandemics/prevention & control; Pneumonia, Viral/complications; Pneumonia, Viral/prevention & control; Transplant Recipients; Betacoronavirus; COVID-19; Clinical Trials as Topic; Communicable Disease Control; Disease Susceptibility; Humans; Organ Transplantation; SARS-CoV-2; Viral Load

Keywords

antibiotic: antiviral; clinical decision-making; complication: infectious; cytokines/cytokine receptors; editorial/personal viewpoint; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; organ transplantation in general

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Immunocompromised Host / Coronavirus Infections / Pandemics / Transplant Recipients Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2020 Document Type: Article Affiliation country: Ajt.15890

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google